Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

Guggulsterone Activates Adipocyte Beiging through Direct Effects on 3T3-L1 Adipocytes and Indirect Effects Mediated through RAW264.7 Macrophages.

Miller CN, Samuels JS, Azhar Y, Parmar A, Shashidharamurthy R, Rayalam S.

Medicines (Basel). 2019 Jan 31;6(1). pii: E22. doi: 10.3390/medicines6010022.

2.

Caffeic acid phenethyl ester exerts apoptotic and oxidative stress on human multiple myeloma cells.

Marin EH, Paek H, Li M, Ban Y, Karaga MK, Shashidharamurthy R, Wang X.

Invest New Drugs. 2018 Nov 22. doi: 10.1007/s10637-018-0701-y. [Epub ahead of print]

PMID:
30465316
3.

Novel anti-obesity effects of beer hops compound xanthohumol: role of AMPK signaling pathway.

Samuels JS, Shashidharamurthy R, Rayalam S.

Nutr Metab (Lond). 2018 Jun 15;15:42. doi: 10.1186/s12986-018-0277-8. eCollection 2018.

4.

Prostaglandin E2 and IL-23 interconnects STAT3 and RoRγ pathways to initiate Th17 CD4+ T-cell development during rheumatoid arthritis.

Samuels JS, Holland L, López M, Meyers K, Cumbie WG, McClain A, Ignatowicz A, Nelson D, Shashidharamurthy R.

Inflamm Res. 2018 Jul;67(7):589-596. doi: 10.1007/s00011-018-1153-8. Epub 2018 Apr 30. Review.

5.

Effects of anchor structure and glycosylation of Fcγ receptor III on ligand binding affinity.

Jiang N, Chen W, Jothikumar P, Patel JM, Shashidharamurthy R, Selvaraj P, Zhu C.

Mol Biol Cell. 2016 Nov 7;27(22):3449-3458. Epub 2016 Aug 31.

6.

Microbiota-inducible Innate Immune, Siderophore Binding Protein Lipocalin 2 is Critical for Intestinal Homeostasis.

Singh V, Yeoh BS, Chassaing B, Zhang B, Saha P, Xiao X, Awasthi D, Shashidharamurthy R, Dikshit M, Gewirtz A, Vijay-Kumar M.

Cell Mol Gastroenterol Hepatol. 2016 Jul;2(4):482-498.e6.

7.

Immune Complex-Induced, Nitric Oxide-Mediated Vascular Endothelial Cell Death by Phagocytes Is Prevented with Decoy FcγReceptors.

Mula RV, Machiah D, Holland L, Wang X, Parihar H, Sharma AC, Selvaraj P, Shashidharamurthy R.

PLoS One. 2016 Apr 21;11(4):e0153620. doi: 10.1371/journal.pone.0153620. eCollection 2016.

8.

Antibody effector functions mediated by Fcγ-receptors are compromised during persistent viral infection.

Wieland A, Shashidharamurthy R, Kamphorst AO, Han JH, Aubert RD, Choudhury BP, Stowell SR, Lee J, Punkosdy GA, Shlomchik MJ, Selvaraj P, Ahmed R.

Immunity. 2015 Feb 17;42(2):367-378. doi: 10.1016/j.immuni.2015.01.009. Epub 2015 Feb 10.

9.

Discovery and characterization of carbamothioylacrylamides as EP2 selective antagonists.

Ganesh T, Jiang J, Shashidharamurthy R, Dingledine R.

ACS Med Chem Lett. 2013 Jul 11;4(7):616-621.

10.

Expression of membrane anchored cytokines and B7-1 alters tumor microenvironment and induces protective antitumor immunity in a murine breast cancer model.

Bozeman EN, Cimino-Mathews A, Machiah DK, Patel JM, Krishnamoorthy A, Tien L, Shashidharamurthy R, Selvaraj P.

Vaccine. 2013 May 7;31(20):2449-56. doi: 10.1016/j.vaccine.2013.03.028. Epub 2013 Mar 28.

11.

Differential role of lipocalin 2 during immune complex-mediated acute and chronic inflammation in mice.

Shashidharamurthy R, Machiah D, Aitken JD, Putty K, Srinivasan G, Chassaing B, Parkos CA, Selvaraj P, Vijay-Kumar M.

Arthritis Rheum. 2013 Apr;65(4):1064-73. doi: 10.1002/art.37840.

12.

Immunotherapeutic strategies for cancer treatment: a novel protein transfer approach for cancer vaccine development.

Shashidharamurthy R, Bozeman EN, Patel J, Kaur R, Meganathan J, Selvaraj P.

Med Res Rev. 2012 Nov;32(6):1197-219. doi: 10.1002/med.20237. Epub 2011 Jan 16. Review.

PMID:
23059764
13.

Lipocalin 2 deficiency dysregulates iron homeostasis and exacerbates endotoxin-induced sepsis.

Srinivasan G, Aitken JD, Zhang B, Carvalho FA, Chassaing B, Shashidharamurthy R, Borregaard N, Jones DP, Gewirtz AT, Vijay-Kumar M.

J Immunol. 2012 Aug 15;189(4):1911-9. doi: 10.4049/jimmunol.1200892. Epub 2012 Jul 11.

14.

Oral microparticulate vaccine for melanoma using M-cell targeting.

D'Souza B, Bhowmik T, Shashidharamurthy R, Oettinger C, Selvaraj P, D'Souza M.

J Drug Target. 2012 Feb;20(2):166-73. doi: 10.3109/1061186X.2011.622395. Epub 2011 Oct 10.

PMID:
21981679
15.

A novel microparticulate vaccine for melanoma cancer using transdermal delivery.

Bhowmik T, D'Souza B, Shashidharamurthy R, Oettinger C, Selvaraj P, D'Souza MJ.

J Microencapsul. 2011;28(4):294-300. doi: 10.3109/02652048.2011.559287.

PMID:
21545320
16.

'Exhaustive' look at PD-1/PDL-1 blockade in vivo.

Bozeman EN, Hood JD, Shashidharamurthy R, Selvaraj P.

Immunotherapy. 2009 Jul;1(4):525-7. doi: 10.2217/imt.09.37. No abstract available.

17.

Immune complex-mediated enhancement of secondary antibody responses.

Goins CL, Chappell CP, Shashidharamurthy R, Selvaraj P, Jacob J.

J Immunol. 2010 Jun 1;184(11):6293-8. doi: 10.4049/jimmunol.0902530. Epub 2010 May 3.

18.

Cancer vaccine development: designing tumor cells for greater immunogenicity.

Bozeman EN, Shashidharamurthy R, Paulos SA, Palaniappan R, D'Souza M, Selvaraj P.

Front Biosci (Landmark Ed). 2010 Jan 1;15:309-20.

19.

Dynamics of the interaction of human IgG subtype immune complexes with cells expressing R and H allelic forms of a low-affinity Fc gamma receptor CD32A.

Shashidharamurthy R, Zhang F, Amano A, Kamat A, Panchanathan R, Ezekwudo D, Zhu C, Selvaraj P.

J Immunol. 2009 Dec 15;183(12):8216-24. doi: 10.4049/jimmunol.0902550.

20.

Surface engineering of microparticles by novel protein transfer for targeted antigen/drug delivery.

Bumgarner GW, Shashidharamurthy R, Nagarajan S, D'Souza MJ, Selvaraj P.

J Control Release. 2009 Jul 20;137(2):90-7. doi: 10.1016/j.jconrel.2009.03.011. Epub 2009 Mar 26.

PMID:
19328830

Supplemental Content

Loading ...
Support Center